EP3456340
GLP-1 VIÐTAKA MÓTLYF TIL NOTKUNAR VIÐ MEÐHÖNDLUN Á MEÐFÆDDRI INSÚLÍNSÝKI
:
EP einkaleyfi í gildi á Íslandi:
8.1.2008:
16.2.2022:
18201976.0
:
12.4.2022:
15.5.2022
:
7.1.2028:
7.1.2026:
31.1.2026
:
GLP-1 RECEPTOR ANTAGONIST FOR USE IN THE TREATMENT OF CONGENITAL HYPERINSULINISM
8.1.2008
16.2.2022
12.4.2022
15.5.2022
7.1.2026
:
The Trustees of the University of Pennsylvania:
3160 Chestnut Street, Suite 200, Philadelphia, PA 19104-6283, US
:
Children's Hospital of Philadelphia:
3401 Civic Center Boulevard, Philadelphia, PA 19104, US
:
STOFFERS, Doris:
Moorestown, NJ New Jersey 08057, US
:
DE LEON, Diva D:
Penn Valley, PA Pennsylvania 19072, US
:
STANLEY, Charles:
Drexel Hil, PA Pennsylvania 19026, US
:
Novagraaf Brevets:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
:
87903307 P:
8.1.2007:
US
:
A61K 38/26, A61P 3/10
: 16
: 13.12.2022
: 7.1.2024
: Árnason Faktor ehf.
: 17
: 18.12.2023
: 7.1.2025
: Árnason Faktor ehf.
: 18
: 10.12.2024
: 7.1.2026
: Árnason Faktor ehf.